Frank Karbe - Jul 27, 2023 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Chief Executive Officer, Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Stock symbol
BTTX
Transactions as of
Jul 27, 2023
Transactions value $
$100,000
Form type
4
Date filed
7/31/2023, 07:58 AM
Previous filing
May 30, 2023
Next filing
Dec 20, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $100K +137K +46.85% $0.73 429K Jul 27, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 25, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.7299 per share.
F2 As one of the PIPE Investors, the Reporting Person acquired 137,005 shares of Issuer common stock on July 27, 2023 for $0.7299 per share.

Remarks:

Chief Executive Officer, President, Treasurer and Secretary